Your browser doesn't support javascript.
loading
Dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF-mutant solid tumors.
Mooradian, Meghan J; Cleary, James M; Giobbie-Hurder, Anita; Darville, Lancia N F; Parikh, Aparna; Buchbinder, Elizabeth I; Cohen, Justine V; Lawrence, Donald P; Shapiro, Geoffrey I; Keer, Harold; Chen, Helen X; Ivy, Susan Percy; Smalley, Keiran S M; Koomen, John M; Sullivan, Ryan J.
Afiliação
  • Mooradian MJ; Division of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Cleary JM; Harvard Medical School, Boston, Massachusetts, USA.
  • Giobbie-Hurder A; Harvard Medical School, Boston, Massachusetts, USA.
  • Darville LNF; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Parikh A; Division of Biostatistics, Departments of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Buchbinder EI; Department of Proteomics and Metabolomics Core, Moffitt Cancer Center, Tampa, Florida, USA.
  • Cohen JV; Division of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Lawrence DP; Harvard Medical School, Boston, Massachusetts, USA.
  • Shapiro GI; Harvard Medical School, Boston, Massachusetts, USA.
  • Keer H; Division of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Chen HX; Division of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Ivy SP; Harvard Medical School, Boston, Massachusetts, USA.
  • Smalley KSM; Division of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Koomen JM; Harvard Medical School, Boston, Massachusetts, USA.
  • Sullivan RJ; Harvard Medical School, Boston, Massachusetts, USA.
Cancer ; 129(12): 1904-1918, 2023 06 15.
Article em En | MEDLINE | ID: mdl-37042037
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Melanoma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos